This is fundamentally different from how semaglutide and other GLP-1 drugs work
One conceived in the wake of recombinant DNA technology in the 70s, shaped by early anglerfish experiments in the 80s, and given further structure by elegant biochemical studies of GPCR signaling in the 90s
Zepbound which has the active ingredient tirzepatide is a once-weekly injection thats FDA-approved for weight loss
Where the field goes next The EVOKE/EVOKE+ results reinforce that singlemechanism interventions may not be sufficient to modify Alzheimers course in symptomatic stages
This review will use the term MASLD, defined as the presence of hepatic steatosis with no other discernible cause, in conjunction with at least one cardiometabolic risk factor (CMRF), such as type 2 diabetes mellitus (T2DM), obesity, hypertension, or dyslipidemia